Secondly, Nabissi et al. [50] demonstrated that CBD treatment upregulated the expression of acute myeloid leukaemia (Aml-1) transcription factors, inducing autophagy and GSC de-differentiation, abrogating the chemoresistance of GSCs to chemotherapeutics. Here, RUNX1 is linked to myeloid leukemia.